NIOX Group Plc (LON:NIOX) Insider Purchases £11,587.52 in Stock

NIOX Group Plc (LON:NIOX - Get Free Report) insider Ian Johnson bought 144,844 shares of NIOX Group stock in a transaction dated Wednesday, June 25th. The stock was purchased at an average cost of GBX 8 ($0.11) per share, for a total transaction of £11,587.52 ($15,897.27).

Ian Johnson also recently made the following trade(s):

• On Tuesday, May 20th, Ian Johnson sold 3,924,630 shares of NIOX Group stock. The shares were sold at an average price of GBX 65 ($0.89), for a total transaction of £2,551,009.50 ($3,499,807.24).

NIOX Group Trading Up 3.7%

Shares of LON NIOX traded up GBX 2.40 ($0.03) during mid-day trading on Friday, reaching GBX 68 ($0.93). The company had a trading volume of 406,879 shares, compared to its average volume of 1,198,524. The business's 50-day moving average is GBX 65.83 and its 200-day moving average is GBX 64.44. The company has a current ratio of 6.31, a quick ratio of 1.94 and a debt-to-equity ratio of 1.10. The stock has a market cap of £27.93 billion, a price-to-earnings ratio of 2,806.24 and a beta of 0.92. NIOX Group Plc has a 52 week low of GBX 53.40 ($0.73) and a 52 week high of GBX 80 ($1.10).

NIOX Group (LON:NIOX - Get Free Report) last posted its quarterly earnings results on Tuesday, April 1st. The company reported GBX 2.27 ($0.03) EPS for the quarter. NIOX Group had a net margin of 28.21% and a return on equity of 13.29%. Equities analysts expect that NIOX Group Plc will post 1.1658256 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have recently weighed in on NIOX. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a GBX 90 ($1.23) target price on shares of NIOX Group in a research note on Tuesday, April 15th. Berenberg Bank restated a "buy" rating and issued a GBX 90 ($1.23) price target on shares of NIOX Group in a report on Tuesday, April 15th.

NIOX Group Company Profile

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.